Access to hematopoietic stem cell transplant for patients with sickle cell anemia

被引：4

作者：

Meier, Emily Riehm ^{[1
]}

Johnson, Theodore ^{[2
]}

Pinkney, Kerice ^{[3
]}

Velez, Maria C. ^{[4
]}

Kamani, Naynesh ^{[5
]}

Odame, Isaac ^{[6
]}

机构：

[1] Indiana Hemophilia & Thrombosis Ctr, 8326 Naab Rd, Indianapolis, IN 46220 USA

[2] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA

[3] Joe DiMaggio Childrens Hosp, Div Pediat Hematol Oncol, Hollywood, FL USA

[4] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Childrens Hosp, New Orleans, LA USA

[5] AABB, Bethesda, MD USA

[6] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada

来源：

PEDIATRIC BLOOD & CANCER | 2018年 / 65卷 / 09期

关键词：

diversity; healthcare disparities; hematopoietic stem cell transplant; hydroxyurea; sickle cell anemia; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; HEALTH-CARE; ACADEMIC MEDICINE; CONTROLLED-TRIAL; UNITED-STATES; DISEASE; RISK; US;

D O I：

10.1002/pbc.27105

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

引用

页数：5

共 50 条

[41] Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease
Hulbert, Monica L.
Fields, Melanie E.
Guilliams, Kristin P.
Bijlani, Priyesha
Shenoy, Shalini
Fellah, Slim
Towerman, Alison S.
Binkley, Michael M.
McKinstry, Robert C.
Shimony, Joshua S.
Chen, Yasheng
Eldeniz, Cihat
Ragan, Dustin K.
Vo, Katie
An, Hongyu
Lee, Jin-Moo
Ford, Andria L.
BLOOD, 2023, 141 (04) : 335 - 344
[42] HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SICKLE CELL DISEASE, EXPERIENCE OF THE PEDIATRIC TRANSPLANT CENTER IN GRAZ
Schwinger, W.
Sperl, D.
Lackner, H.
Perwein, T.
Seidel, M.
Karastaneva, A.
Benesch, M.
TRANSPLANT INTERNATIONAL, 2019, 32 : 20 - 21
[43] Allogeneic hematopoietic stem cell transplant in children and adults with sickle cell disease: Indications and modalities
Dhedin, Nathalie
Paillard, Catherine
Dalle, Jean-Hugues
Ouachee, Marie
Buchbinder, Nimrod
Brissot, Eolia
Beguin, Yves
Masouridi-Levrat, Stavroula
Yakoub-Agha, Ibrahim
Bernit, Emmanuelle
Pondarre, Corinne
BULLETIN DU CANCER, 2020, 107 (09) : 925 - 933
[44] Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease
Inam, Zaina
Tisdale, John F.
Leonard, Alexis
EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (11) : 879 - 903
[45] Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Booth, Natalie
Ngwube, Alexander
Appavu, Brian
Shah, Sanjay
Abruzzo, Todd
PEDIATRICS, 2024, 153 (02)
[46] THE HEMATOPOIETIC AND GOITROGENIC EFFECTS OF COBALTOUS CHLORIDE IN PATIENTS WITH SICKLE CELL ANEMIA
GROSS, RT
KRISS, JP
SPAET, TH
PEDIATRICS, 1955, 15 (03) : 284 - 290
[47] Hematopoietic stem cell transplantation in sickle cell disease
Vermylen, C
BLOOD REVIEWS, 2003, 17 (03) : 163 - 166
[48] Inpatient Rehabilitation of Hematopoietic Stem Cell Transplant Patients
Fu, Jack B.
Morishita, Shinichiro
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2024, 103 (3S) : S46 - S51
[49] Music Therapy for the Hematopoietic Stem Cell Transplant Patients
Estrella, Joylyn Mae
Dela Cruz, Buenagracia
Blackburn, Roxann
Buitrago, Joaquin A.
Moeller, Ingrid
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S262 - S263
[50] HSV resistance in hematopoietic stem cell transplant patients
Marxova, M.
Hladikova, S.
Kabatova, K.
Karas, M.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 434 - 434

← 1 2 3 4 5 →